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Neuropatia periferică în scleroza multiplă – aspecte clinice şi electrofiziologice
La un lot de 50 de pacienţi, cu scleroză multiplă clinic şi imagistic definită, au fost studiate manifestările clinice şi electrofiziologice de afectare 
a fibrelor nervilor periferici. Deşi semnele clinice de neuropatie la aceşti pacienţi se determină doar ocazional, examenul de stimulodetecţie 
frecvent (în 28% din cazuri) pune în evidenţă existenţa subclinică a unei neuropatii periferice, manifestate prin diminuarea vitezei de conducere, 
majorarea latenţei distale şi latenţei răspunsurilor tardive (undei-F). Procesul patologic în cadrul sclerozei multiple nu se limitează la demielinizarea 
fibrelor sistemului nervos central, dar se extinde şi la radiculele nervoase, fibrele motorii şi sensorii ale nervilor periferici.
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Периферическая невропатия при рассеянном склерозе. Клинические и электрофизиологические аспекты
В группе из 50 больных рассеянным склерозом были исследованы клинические и электрофизиологические проявления поражения 
волокон периферических нервов. Несмотря на то, что у этих больных клинические признаки невропатии определяются лищь изредка, 
при исследовании проведения нервных импульсов выявлено частое (в 28% случаях) доклиническое проявление периферической 
невропатии, проявляющейся снижением скорости проведения, увеличением дистальной латентности и латентности поздних ответов 
(F-волны). Патологический процесс при рассеянном склерозе не ограничивается демиелинизацией волокон центральной нервной 
системы, он распространяется и на нервные корешки спинного мозга и на двигательные и чувствительные волокна периферических 
нервов.
Ключевые слова: рассеянный склероз, демиелинизация, невропатия, электрофизиология.
Introduction
Multiple sclerosis (MS) is a demyelinating disease of 
the central nervous system (CNS). The majority of the white 
matter lesions are localized in the periventricular region and 
at the level of junction between white and gray brain matter. 
MS is the main cause of disability in young adults. There are 
approximately 1, 1 – 2, 5 million patients of MS in the world. 
Annually, there are registered about 10.000 new cases. 
Although MS has classically been considered a CNS de-
myelinating disease, there have been occasional reports of pe-
ripheral nervous system (PNS) involvement. Both peripheral 
neuropathy [6] and radiculopathy [8] have been reported in 
MS patients. Subclinical pathologic [3] and electrophysiologic 
[7] abnormalities have also been reported in association with 
MS. Even though these associations are well documented, the 
frequency of neuropathy in MS patients has not been clearly 
defined. On the other hand, central demielinating lesions have 
been seen by means of magnetic resonance imaging (MRI) and 
evoked potentials in some patients with chronic inflammatory 
demyelinating polyradiculoneuropathy [2, 8].
The goal of this study was to establish the clinical and 
electrophysiological peculiarities of PNS involvement in 
cases of MS.
Material and methods
 There were 50 patients examined, diagnosed with definite 
MS according to the McDonald criteria. The age of the patients 
varied between 15 and 49 years (mean age 33, 4 years). Each case 
was documented by means of MRI examination. Patients with 
diseases that can develop neuropathy, such as diabetes mellitus, 
thyroid pathology, renal and hepatic failure, and alcohol abuse 
were excluded from the study. Excluded as well, were patients 
with a possible mechanical nerve compression.
 Recurrent remissive evolution of MS was established in 33 
patients (66% of cases). In the other 17 patients (34% of cases), 
primary progressive form was revealed. The EDSS/Kurtzke score 
varied between 2, 0 and 6, 5 (mean value – 4, 42). 
 Nerve conduction studies were performed in the fibers 
of medianus, ulnaris, radialis, peroneus communis, tibialis and 
suralis nerves. Studied were the distal latencies, nerve conduc-
tion velocities in the motor and sensory fibers, amplitude of 
the compound muscle action potential, and amplitude of the 
sensory potentials and latency of the F-waves. 
Results
The clinical manifestations and electrophysiological 
pattern of the peripheral neuropathy was studied in MS pa-
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tients by evaluation of neuropathic symptoms and signs, and 
electrophysiological studies. The patients with sensory and 
motor complaints had mild symptoms and signs suggestive 
of neuropathy.
Clinical signs of PNS impairment were established in 6 
patients (12% of cases). They consisted in the diminishing of 
ankle reflexes, sensory disturbances in „socks” and „gloves” 
distribution, and signs of sensory ataxia.
There was no significant correlation between any of the 
clinical variables of MS with the occurrence of neuropathy.
Electrophysiological signs of subclinical damage of the 
peripheral nerves were detected rather more often. Modi-
fications justifying the polyneuropathy were established in 
14 patients (28% of cases). They consisted in a statistically 
significant prolongation of the distal latencies, reduction 
of the motor and sensory nerve conduction velocities, and 
prolongation of the latencies of the F waves in at least 3-6 of 
nerves examined.
A typical finding of nerve conduction in a patient with 
PNS involvement in MS is presented in figs. 1 and 2.
Discussions
Peripheral neuropathy in combination with MS was 
documented by several authors and it remains unclear if 
they are part of the same entity or coincidental findings. 
Pollock et al. [5] performed sural nerve biopsy on 10 MS 
Fig.1. Nerve conduction studies in the motor fibers of the peroneus communis nerve. Specific signs for demyelinating neuropathy 
– significant increase of the distal latency (7,3 ms), and decrease of the motor conduction velocity – 38,3 m/s.
Fig. 2. Nerve conduction studies in the motor fibers of the tibialis nerve. Specific signs for demyelinating neuropathy – increase of the 
distal latency (6,0 ms), and significant decrease of the motor conduction velocity – 30,5 m/s.
patients without any clinical evidence of peripheral neurop-
athy. Surprisingly, normal conduction studies in the fibers 
of the sural nerve find a high frequency of abnormal teased 
fibers and significant reduction of the myelin thickness, 
suggesting that peripheral myelin may be also involved in 
MS. Lassman et al. [3] showed abnormal autopsy findings 
consisting in widespread demyelination and inflamma-
tory cells in the nerve roots of a patient with MS without 
discovering any clinical and neurophysiological evidence 
of peripheral nerve involvement. Hasson et al. observed 
slight to severe demyelination of the peripheral nerves in 
12 out of 20 autopsied MS patients, but considered that 
they were related to malnutrition and avitaminosis. Conrad 
and Bechinger reported mild slowing with prolonged distal 
latencies in a portion of patients with MS upon performing 
nerve conduction studies. Sarova-Pinhas et al. [7] registered 
electrophysiological abnormalities in 10 out of 22 mildly 
disabled MS patients. In a study performed by Marchioni 
et al. [4] of 60 adults with postinfectious central nervous 
system demyelinating disease, 44% of the patients exhibited 
simultaneous PNS involvement in the form of polyradicu-
loneuropathy (clinically obvious in 38% of them).
In our study, we revealed clinical signs of neuropathy 
in 6 patients (12% of cases) out of 50 studied, with electro-
physiological abnormalities of nerve conduction suggesting a 
demyelinating neuropathy in 14 patients (28% of cases).
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It has been postulated that peripheral nerve involve-
ment in MS may be associated with advanced disease and 
immobilization [5]. But other researchers did not find such 
an association, despite their ability to review the clinical 
course longitudinally. Furthermore, in 2 patients peripheral 
neuropathy was the initial manifestation. The occurrence of 
radiculopathy has been explained on the basis of junctional 
(root entry zone) lesions or plaques. This mechanism, howev-
er, could not explain the occurrence of peripheral neuropathy. 
In the CNS demyelinating animal model, chronic relapsing 
of experimental allergic encephalomyelitis and peripheral 
nerve demyelination is also known to occur. Recent studies 
suggest that common antigens are shared by both periph-
eral and central myelin. One such antigen that has recently 
been identified is myelin-associated glycoprotein. Antigenic 
cross-reactivity between CNS and PNS myelin proteins or 
multiple antigens (some not yet identified) may elicit similar 
immune responses, producing demyelination. Alternatively, 
MS patients with PNS involvement may represent a clinical 
subset sharing a common alteration of the immune response 
to peripheral and central myelin antigens. 
On the other hand, Thomas et al. [9] examined 6 patients 
with CIDP associated with multifocal CNS demyelination. 
Recently, Sharma et al. [8] described 5 patients with CIDP 
associated with MS.
We consider that the inflammatory diseases that affect 
myelin of the PNS and CNS could be considered within a 
spectrum in relation with the pole of the spectrum which is 
predominantly affected. In the majority of cases, the patho-
logical process is localized at one of the poles of the spectrum, 
but there also exist cases in which the myelin of both CNS 
and PNS suffers. One of the poles of the spectrum is occupied 
by MS, in which demyelination occurs mainly at the level 
of the CNS. Rarely in cases of MS are there clinical signs of 
PNS damage, but the subclinical signs of such a process are 
established rather more frequently.
There were studies published about combined central 
and peripheral nervous system demyelination. Adamovic et al. 
[1] observed over a 13-year period, 13 patients of the pediatric 
population with severe acute combined central and peripheral 
nervous system demyelination. They found this to account for 
14% of children with acute acquired demyelination. Most pre-
sented itself during the winter, with both constitutional and 
neurologic signs present at admission. The onset of neurologic 
disturbance was preceded by an infectious prodrome in 84.6% 
of cases. However, the suspected infectious agent could only 
be identified in 38.5% of patients. Similarly to patients with 
classic acute disseminated encephalomyelitis, the patients with 
combined central and peripheral nervous system demyelization 
manifested a wide variability of multifocal neurologic deficits, 
mostly exhibiting signs of encephalopathy or spinal cord dys-
function. The authors found poor neurologic evolution and a 
final outcome of 7 (54%) patients with acute combined central 
and peripheral nervous system demyelization. Classic acute dis-
seminated encephalomyelitis is typically a disease characterized 
by a good evolution and excellent neurologic outcome. Cases 
with residual neurologic and cognitive deficit, or even death, are 
rarely observed. The same applies to Guillain-Barré syndrome. 
A pediatric study on transverse myelitis demonstrated an overall 
poor outcome, with 40% of children permanently wheelchair-
dependent as a result of the disease. The authors concluded that 
the optimal therapeutic options for acute combined central and 
peripheral nervous system demyelization are still uncertain, and 
the question of which treatment to use first (corticosteroids, 
intravenous gammaglobulins) remains unanswered.
The prevalence of acute combined central and peripheral 
nervous system demyelization was probably underestimated, 
because most of the patients with acute isolated CNS and acute 
isolated PNS demyelization were not systematically evaluated 
for possible associated involvement (magnetic resonance im-
aging and/or nerve conduction studies). Some patients with 
mild involvement were possibly overlooked because these 
investigations were not undertaken. 
 Acute combined central and peripheral nervous system 
demyelization is not as rare as previously thought. Although 
isolated CNS or PNS demyelization usually portends a good 
prognosis, the combination of these two diseases may have, 
in some patients, a poorer prognosis. Systematic assessment 
of this entity, using MRI and EMG/NCS is important. Further 
studies are necessary to clarify its incidence, risk factors, po-
tential etiologies, optimal management, and prognosis.
The occurrence of both CNS and PNS demyelization 
raises the question of common pathogenetic mechanisms and 
may represent a unique disorder with a distinct pathogenesis. 
Peripheral myelin P1 protein is shared by both peripheral and 
central myelin. Based on animal studies and studies in humans 
[10] there are clear parallels, both clinical and histopathologi-
cal, between the events in experimental allergic neuritis and 
experimental allergic encephalomyelitis where combined PNS 
and CNS demyelization may occur. Therefore it is possible 
that the initial autoimmune response to myelin basic protein 
or myelin P1 might have increased the damage to the primary 
antigens site in peripheral or CNS by exposing other antigenic 
epitopes in myelin antigens. Probably during an autoimmune 
process directed against such epitopes in central or peripheral 
myelin, the autoimmune-mediated demyelization could ex-
tend from the CNS to PNS and present itself as demyelinating 
disease of the CNS (MS) and PNS (CIDP).
Conclusions
PNS involvement in MS may be more frequent than is 
generally assumed. Often only subclinical (electrophysiologi-
cal) signs can be established. Nerve conduction studies esti-
mate the degree of PNS involvement in MS patients. Patients 
with both peripheral and central demyelization may represent 
a subpopulation in which further studies might identify spe-
cific antigens of pathophysiologic significance.
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Asigurarea hemostazei locale în chirurgia orală  
prin utilizarea trombinei umane la persoanele  
cu sindrom hemoragipar de diversă etiologie 
O. Zănoagă
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Maintenance of Local Haemostasis in Oral Surgery using Human Thrombin in Patients with Bleeding Disorders  
of Different Etiology
The author analysed the results at 67 patients hospitalized in the OMF Surgery Department of CNSPMU, Chisinau, between April, 2007 and 
February, 2009 who required treatment for oral bleeding.  53 patients suffered bleeding after tooth extraction, 9 gingival bleeding, and 5 bleeding 
after periostotomy.  The study showed that  human thrombin used as a haemostatic remedy is physiologically effective, inoffensive  in treating 
bleeding of different etiologies, and that it avoids the deficiencies of classical methods of haemostasis.
Key words: bleeding, haemostasis, thrombin.
Обеспечение локального гемостаза в оральной хирургии с использованием человеческого тромбина  
у пациентов с геморрагическим синдромом разной этиологии 
Исследование было основано на анализе результатов полученных в группе из 67 пациентов, госпитализированных в отделение 
ЧЛХ ННПЦУМ г. Кишинэу, в период апрель 2007 – февраль 2009. Эти пациенты обратились за медицинской помощью с жалобами 
на наличие кровотечения из ротовой полости. Из них у 53-х кровотечение после зубного удаления, у 9-х – десневое кровотечение 
и у 5-х – кровотечение после периостотомии. Было доказано, что использование человеческого тромбина с гемостатической целью 
является физиологическим, эффективным и безопасным методом остановки кровотечений разной этиологии, к тому же не обладает 
недостатками классического метода гемостаза.
Ключевые слова: геморрагия, гемостаз, тромбин.
Actualitatea temei
În cavitatea bucală se deosebesc hemoragii idiopatice şi 
iatrogene [1]. Hemoragiile idiopatice apar spontan în cazul 
exulcerării tumorilor, a bolilor hemoragipare şi în cadrul 
unor forme a parodontopatiilor, iar cele iatrogene – în urma 
intervenţiilor chirurgicale.
De cele mai dese ori, în vederea acordării asistenţei 
medicale specializate, se recurge la utilizarea măsurilor locale 
de hemostază prin aplicarea suturilor, a tamponamentului 
compresiv supra- sau intraalveolar, electro- sau diatermo-
coagularea ţesuturilor sângerânde, aplicarea cristalelor de 
permanganat de caliu sau a preparatelor hemostatice [2]. 
Este demonstrat că, injectarea adrenalinei oferă doar un efect 
hemostatic temporar, iar utilizarea metodelor termice de 
hemostază provoacă o necroză tisulară şi încetinesc conside-
rabil procesele de vindecare [2]. Aplicarea suturilor provoacă 
